Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios
Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.
Zacks Investment Research7/7/2026Positive
BEAT
Heartbeam IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$36.58M
P/E Ratio
—
EPS
$-0.56
Beta
-0.83
52W High
$4.00
52W Low
$0.54
50-Day MA
$0.83
200-Day MA
$1.40
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Heartbeam Inc
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.29M |
| Operating Margin | 0.00% |
| Return on Equity | -495.60% |
| Return on Assets | -195.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.01 |
| Price-to-Book | 62.93 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.00 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $55.51M |
| Float | $47.45M |
| % Insiders | 13.90% |
| % Institutions | 9.27% |
Historical Volatility
HV 10-Day
100.79%
HV 20-Day
81.45%
HV 30-Day
71.75%
HV 60-Day
97.07%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($3.83 target)
1
Strong Buy3
Buy1
HoldLatest News
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule.
Business Wire6/30/2026Neutral
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition.
Business Wire6/24/2026Positive
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home.
Business Wire6/2/2026Neutral
HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know
HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research5/27/2026Positive
HeartBeam Reports First Quarter 2026 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.
Business Wire5/13/2026Neutral
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic.
Business Wire5/11/2026Neutral
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time.
Business Wire4/30/2026Neutral
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Closing of $10 Million Public Offering of Common Stock.
Business Wire4/16/2026Neutral
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock.
Business Wire4/15/2026Neutral
More HEALTHCARE Stocks
Data last updated: 7/9/2026